PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21400122-8	2012	Mice treated with midazolam had significantly lower serum IL-1beta (p=0.002), TNF-alpha (p=0.002), IL-6 (p=0.016), IL-10 (p=0.009), and TGF-beta (p=0.004) than saline-treated mice, with little impact on serum chemokine levels.	Midazolam	18-27	tumor necrosis factor	Mus musculus	78-87	
30670973-6	2018	Mechanistically, midazolam suppressed tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) produced by LPS stimulated liver macrophages in vivo and bone marrow monocytes in vitro, and reduced the expression of major histocompatibility complex class II (MHC II), cluster of differentiation 40 and 86 (CD40 and CD86) on the cell surface.	Midazolam	17-26	tumor necrosis factor	Mus musculus	38-65	
30670973-6	2018	Mechanistically, midazolam suppressed tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) produced by LPS stimulated liver macrophages in vivo and bone marrow monocytes in vitro, and reduced the expression of major histocompatibility complex class II (MHC II), cluster of differentiation 40 and 86 (CD40 and CD86) on the cell surface.	Midazolam	17-26	tumor necrosis factor	Mus musculus	67-76	
8031051-2	1994	Midazolam and 4"-chlorodiazepam significantly suppressed LPS (1-microgram/ml)-induced TNF activity in thioglycolate-elicited mouse macrophages.	Midazolam	0-9	tumor necrosis factor	Mus musculus	86-89